157 related articles for article (PubMed ID: 34328113)
1. The influence of biologics on the microbiome in immune-mediated inflammatory diseases: A systematic review.
Ruszkowski J; Daca A; Szewczyk A; Dębska-Ślizień A; Witkowski JM
Biomed Pharmacother; 2021 Sep; 141():111904. PubMed ID: 34328113
[TBL] [Abstract][Full Text] [Related]
2. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
3. The Gut Microbiome in Inflammatory Bowel Disease: Lessons Learned From Other Immune-Mediated Inflammatory Diseases.
Knox NC; Forbes JD; Peterson CL; Van Domselaar G; Bernstein CN
Am J Gastroenterol; 2019 Jul; 114(7):1051-1070. PubMed ID: 31232832
[TBL] [Abstract][Full Text] [Related]
4. Systematic review: the association between the gut microbiota and medical therapies in inflammatory bowel disease.
Radhakrishnan ST; Alexander JL; Mullish BH; Gallagher KI; Powell N; Hicks LC; Hart AL; Li JV; Marchesi JR; Williams HRT
Aliment Pharmacol Ther; 2022 Jan; 55(1):26-48. PubMed ID: 34751954
[TBL] [Abstract][Full Text] [Related]
5. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.
Raftery AL; Tsantikos E; Harris NL; Hibbs ML
Front Immunol; 2020; 11():2144. PubMed ID: 33042125
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiome in chronic rheumatic and inflammatory bowel diseases: Similarities and differences.
Salem F; Kindt N; Marchesi JR; Netter P; Lopez A; Kokten T; Danese S; Jouzeau JY; Peyrin-Biroulet L; Moulin D
United European Gastroenterol J; 2019 Oct; 7(8):1008-1032. PubMed ID: 31662859
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiome in primary sclerosing cholangitis: A review.
Little R; Wine E; Kamath BM; Griffiths AM; Ricciuto A
World J Gastroenterol; 2020 Jun; 26(21):2768-2780. PubMed ID: 32550753
[TBL] [Abstract][Full Text] [Related]
8. Incidence of Immune-Mediated Inflammatory Diseases Among Patients With Inflammatory Bowel Diseases in Denmark.
Burisch J; Jess T; Egeberg A
Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2704-2712.e3. PubMed ID: 30936024
[TBL] [Abstract][Full Text] [Related]
9. NLRX1 Modulates Immunometabolic Mechanisms Controlling the Host-Gut Microbiota Interactions during Inflammatory Bowel Disease.
Leber A; Hontecillas R; Tubau-Juni N; Zoccoli-Rodriguez V; Abedi V; Bassaganya-Riera J
Front Immunol; 2018; 9():363. PubMed ID: 29535731
[TBL] [Abstract][Full Text] [Related]
10. Carotenoid supplementation and retinoic acid in immunoglobulin A regulation of the gut microbiota dysbiosis.
Lyu Y; Wu L; Wang F; Shen X; Lin D
Exp Biol Med (Maywood); 2018 Apr; 243(7):613-620. PubMed ID: 29534601
[TBL] [Abstract][Full Text] [Related]
11. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
[TBL] [Abstract][Full Text] [Related]
12. The effects of inulin on gut microbial composition: a systematic review of evidence from human studies.
Le Bastard Q; Chapelet G; Javaudin F; Lepelletier D; Batard E; Montassier E
Eur J Clin Microbiol Infect Dis; 2020 Mar; 39(3):403-413. PubMed ID: 31707507
[TBL] [Abstract][Full Text] [Related]
13. Oral and Gut Microbial Diversity and Immune Regulation in Patients with HIV on Antiretroviral Therapy.
Annavajhala MK; Khan SD; Sullivan SB; Shah J; Pass L; Kister K; Kunen H; Chiang V; Monnot GC; Ricupero CL; Mazur RA; Gordon P; de Jong A; Wadhwa S; Yin MT; Demmer RT; Uhlemann AC
mSphere; 2020 Feb; 5(1):. PubMed ID: 32024712
[TBL] [Abstract][Full Text] [Related]
14. Safety of Biologic Therapy in Older Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis.
Borren NZ; Ananthakrishnan AN
Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1736-1743.e4. PubMed ID: 30616024
[TBL] [Abstract][Full Text] [Related]
15. Exploring the links among inflammation and gut microbiome with psychoneurological symptoms and gastrointestinal toxicities in gynecologic cancers: a systematic review.
Barandouzi ZA; Rowcliffe C; Schrogin J; Meador R; Bruner DW
Support Care Cancer; 2022 Aug; 30(8):6497-6513. PubMed ID: 35396962
[TBL] [Abstract][Full Text] [Related]
16. Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease?
Nishida A; Nishino K; Sakai K; Owaki Y; Noda Y; Imaeda H
World J Gastroenterol; 2021 Jun; 27(23):3317-3326. PubMed ID: 34163114
[TBL] [Abstract][Full Text] [Related]
17. Dysbiosis of gut microbiota and its correlation with dysregulation of cytokines in psoriasis patients.
Zhang X; Shi L; Sun T; Guo K; Geng S
BMC Microbiol; 2021 Mar; 21(1):78. PubMed ID: 33685393
[TBL] [Abstract][Full Text] [Related]
18. The Interplay between Immune System and Microbiota in Inflammatory Bowel Disease: A Narrative Review.
Aldars-García L; Marin AC; Chaparro M; Gisbert JP
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802883
[TBL] [Abstract][Full Text] [Related]
19. Feeling down? A systematic review of the gut microbiota in anxiety/depression and irritable bowel syndrome.
Simpson CA; Mu A; Haslam N; Schwartz OS; Simmons JG
J Affect Disord; 2020 Apr; 266():429-446. PubMed ID: 32056910
[TBL] [Abstract][Full Text] [Related]
20. Role of exercise in preventing and restoring gut dysbiosis in patients with inflammatory bowel diseases: A review.
Koutouratsas T; Philippou A; Kolios G; Koutsilieris M; Gazouli M
World J Gastroenterol; 2021 Aug; 27(30):5037-5046. PubMed ID: 34497433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
